Home About Us Products Service News Contact Us    API    -  Oncology    -  Prostaglandins(PG)    -  Antidiabetic    -  Infertility    -  Analgesics of Anesthetics    -  Others    INTERMEDIATE    -  For Paclitaxel    -  For Docetaxel    -  For Repaglinide    -  For Irinotecan    -  For Fludarabine    -  For Etoposide     - Paclitaxel   - Docetaxel Anhydrous   - Irinotecan HCI   - Fludarabine Phosphate   - Bleomycin Sulfate   - Vinorelbine Tartrate   - Argatroban

Home Products Oncology Cytotoxic Tyrosine kinase inhibitor Imatinib Mesylate, Lapatinib, Gefitinib, Dasatinib, Sunitinib, Erlotinib Hcl, Bosutinib Action on DNA chemical structure Carboplatin, Cisplatin, Oxaliplatin, Eptaplatin, Ifosfamide, Bleomycin Sulfate, Temozolomide, Cytarabine Action on nucleic acid synthesis Methotrexate, Gemcitabine HCl, Capecitabine, Pemetrexed Disodium, Tegafur, Fludarabine Phosphate, Decitabine, Ifosfamide Action on topoisomerase inhibitor Irinotecan HCl Action on tubulin synthesis Etoposide, Vinorelbine Tartrate, Paclitaxel, Docetaxel (Anhydrous), Docetaxel(Trihydrate) Oncology Supportive Care   Zoledronic Acid, Palonosetron, Dolasetron, Azasetron Hcl, Ondansetron HCl, Lenalidomide Oncology Hormonal   Anastrozole, Letrozole, Bicalutamide

We will participate at the following exhibitions in 2008 -CPHI India, Nov. 28 - Nov. 30: Stand N0. CP02 (Hall 6) -CPHI Worldwide, Sept. 30-Oct. 02 2008: Stand No. CP51083 -CPHI South America, Aug. 19-21 2008: Stand no. C36 -CPHI Shanghai, 24-26 June. 2008: Stand no. 4F32

Home | About Us | Prdoucts | Service | News | Contact Us Copyright © 2008.All rights reserved.     Design By : POGER Declaration:Shanghai Henghe Pharma-Tech Will not make,sell,offer for commercial sale or export the listed Products in/into regions or countries in which patents are still existing.